Medicinal – Page 40

Insights into the evolution and mechanisms of response to heat stress by whole genome sequencing and comparative proteomics analysis of the domesticated edible mushroom Lepista sordida

mycolabadmin

Researchers sequenced the complete genome of Lepista sordida, a delicious edible mushroom valued for its health benefits, and studied how this mushroom responds to heat stress at the molecular level. Using advanced analysis techniques, they identified key proteins and signaling pathways that help the mushroom survive high temperatures. These findings can help farmers develop better-performing strains that are more resistant to heat, improving mushroom production.

Unveiling the Therapeutic Potentials of Mushroom Bioactive Compounds in Alzheimer’s Disease

mycolabadmin

Mushrooms contain special compounds that may help protect the brain from Alzheimer’s disease. Research shows that eating mushrooms regularly could reduce the risk of memory problems and cognitive decline in older adults. These compounds work by reducing brain inflammation, protecting nerve cells, and helping the brain clear out harmful proteins. While these findings are promising, more human studies are needed to confirm how effective mushrooms are as an Alzheimer’s treatment.

Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers

mycolabadmin

Australian doctors and mental health professionals have positive views about using psychedelics like psilocybin and MDMA to treat depression and trauma, which were recently approved by regulators. However, many still have safety concerns and gaps in their knowledge, particularly psychiatrists. Most doctors learn about psychedelics from podcasts and websites rather than formal training. The study recommends that professional organizations provide better education to prepare healthcare workers for this new treatment approach.

Exo- and Endo-1,5-α-L-Arabinanases and Prebiotic Arabino-Oligosaccharides Production

mycolabadmin

This review explores arabino-oligosaccharides (AOS), special sugar compounds that act as prebiotics to feed beneficial gut bacteria. Scientists use enzymes called arabinanases to produce these AOS from plant material, particularly from arabinan found in sugar beets. Different types of these enzymes create different AOS products with varying health benefits, making them promising ingredients for functional foods and supplements that support digestive health.

Molecular networking identifies an AHR-modulating benzothiazole from white button mushrooms (Agaricus bisporus)

mycolabadmin

Researchers discovered a new compound in white button mushrooms called 2-amino-4-methylbenzothiazole that activates the aryl hydrocarbon receptor, which helps regulate gut health and immunity. Using a computational approach called molecular networking to compare mushroom compounds with known beneficial substances, scientists identified this previously unknown compound and confirmed its activity in laboratory cells. This discovery demonstrates how certain mushrooms may contribute to health through specific bioactive compounds and provides a faster method for finding similar compounds in other foods.

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial

mycolabadmin

This study tests whether psilocybin (the active compound in certain mushrooms) can help people with obsessive-compulsive disorder who haven’t responded to standard treatments. In a carefully controlled trial, participants receive either a single dose of psilocybin or a placebo while receiving psychological support, with their brain activity and symptoms monitored. The research aims to determine if this novel treatment is safe and whether it could work faster than existing medications for this difficult-to-treat condition.

Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey

mycolabadmin

This survey studied how autistic adults feel about using psychedelics like psilocybin mushrooms for mental health. Nearly 70% of participants had tried psychedelics before and most found them helpful for anxiety and depression. Many participants were interested in trying them or participating in research, though legal and practical barriers stood in the way. The study suggests that psychedelics could be a promising treatment option for autistic people with mental health challenges.

Vinigrol Tricyclic Scaffold Biosynthesis Employs an Atypical Terpene Cyclase and a Multipotent Cyclization Cascade

mycolabadmin

Scientists have discovered how a fungus produces vinigrol, a complex molecule with potential health benefits including lowering blood pressure and reducing inflammation. Using advanced computational tools and genetic engineering, researchers identified the specific genes and enzymes the fungus uses to build this molecule’s intricate three-ring structure. By modifying a key enzyme, they were able to create an entirely new diterpene molecule that doesn’t exist in nature, demonstrating the potential to engineer biological systems to produce novel medicinal compounds.

Study protocol for ‘Psilocybin in patients with fibromyalgia: brain biomarkers of action’

mycolabadmin

Researchers are testing whether psilocybin (the active compound in magic mushrooms) combined with therapeutic support can help people with fibromyalgia, a chronic pain condition. The study will measure brain activity using EEG and brain imaging to understand how psilocybin might reduce pain and improve mental health. Twenty patients will receive guided psilocybin sessions over eight weeks while researchers track changes in brain function and pain levels.

The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics

mycolabadmin

Researchers created a new questionnaire called the Afterglow Inventory to measure the positive effects people experience in the days and weeks after using psychedelics like psilocybin and LSD. These ‘afterglow’ effects include improved mood, feelings of spiritual connection, increased creativity, and better relationships. The study with over 1,300 participants showed the questionnaire works well at measuring these effects, which could help researchers better understand how psychedelics might help treat depression and other conditions.

Research Topic: Medicinal